10-K Filing

BIO-TECHNE CORP CIK: 842023 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001437749-15-016645`
Period End Date	20150630
Filing Date	20150831
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	tech-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 69 Cash Flow Statement 107 Stockholders Equity 40 Comprehensive Income 3

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulOtherReceivablesCurrent`	$555.00K	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulOtherReceivablesCurrent`	$487.00K	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$318.57M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$163.79M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$116.67M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$44.79M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$56.39M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $555 and $487, respectively	`AccountsReceivableNetCurrent`	$55.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $555 and $487, respectively	`AccountsReceivableNetCurrent`	$70.03M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$9.62M	USD	Point-in-time
Undesignated capital stock, shares oustanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$11.51M	USD	Point-in-time
Undesignated capital stock, shares oustanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$49.58M	USD	Point-in-time
Inventories	`InventoryNet`	$38.85M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.59M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.24M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$248.28M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	37.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	37.15M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$469.41M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	37.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	37.15M	shares	Point-in-time
Available-for-sale investments	`AvailableForSaleSecuritiesNoncurrent`	$3.58M	USD	Point-in-time
Available-for-sale investments	`AvailableForSaleSecuritiesNoncurrent`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$117.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$129.75M	USD	Point-in-time
Goodwill	`Goodwill`	$390.64M	USD	Point-in-time
Goodwill	`Goodwill`	$84.34M	USD	Point-in-time
Goodwill	`Goodwill`	$151.47M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$108.78M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$40.55M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$292.84M	USD	Point-in-time
Investments in unconsolidated entities	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$10.45M	USD	Point-in-time
Investments in unconsolidated entities	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.85M	USD	Point-in-time
Assets	`Assets`	$778.10M	USD	Point-in-time
Assets	`Assets`	$1.06B	USD	Point-in-time
Assets	`Assets`	$862.49M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$9.65M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$13.44M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$6.16M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$10.34M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.60M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.14M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$3.38M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$496.00K	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.97M	USD	Point-in-time
Related party note payable, current	`NotesPayableRelatedPartiesClassifiedCurrent`	$5.95M	USD	Point-in-time
Related party note payable, current	`NotesPayableRelatedPartiesClassifiedCurrent`	$4.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$39.77M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$33.84M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$61.43M	USD	Point-in-time
Related party note payable, long-term	`NotesPayableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Related party note payable, long-term	`NotesPayableRelatedPartiesNoncurrent`	$7.00M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$73.00M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	-	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	-	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$39.02M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$3.20M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 a share; authorized 100,000,000 shares; issued and outstanding 37,152,979 and 37,002,203 shares, respectively	`CommonStockValue`	$371.00K	USD	Point-in-time
Common stock, par value $.01 a share; authorized 100,000,000 shares; issued and outstanding 37,152,979 and 37,002,203 shares, respectively	`CommonStockValue`	$370.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$163.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$147.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$713.85M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$653.28M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.59M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.39M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$846.93M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$737.54M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$795.26M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$674.44M	USD	Point-in-time
Liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.06B	USD	Point-in-time
Liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$862.49M	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$310.57M	USD	Annual
Net sales	`SalesRevenueNet`	$357.76M	USD	Annual
Net sales	`SalesRevenueNet`	$452.25M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$106.35M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$144.97M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$79.47M	USD	Annual
Gross margin	`GrossProfit`	$307.28M	USD	Annual
Gross margin	`GrossProfit`	$251.41M	USD	Annual
Gross margin	`GrossProfit`	$231.11M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$119.40M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.38M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.72M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$30.95M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$29.26M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$40.85M	USD	Annual
Total operating expenses	`OperatingExpenses`	$72.64M	USD	Annual
Total operating expenses	`OperatingExpenses`	$160.25M	USD	Annual
Total operating expenses	`OperatingExpenses`	$91.66M	USD	Annual
Operating income	`OperatingIncomeLoss`	$147.02K	USD	Annual
Operating income	`OperatingIncomeLoss`	$159.75K	USD	Annual
Operating income	`OperatingIncomeLoss`	$158.47K	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	$1.54M	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest income	`InvestmentIncomeNet`	$2.68M	USD	Annual
Interest income	`InvestmentIncomeNet`	$2.65M	USD	Annual
Interest income	`InvestmentIncomeNet`	$634.00K	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-453.00K	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$8.05M	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.04M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$1.64M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$2.19M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$7.14M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$161.39M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$154.16M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$160.66M	USD	Annual
Income taxes	`IncomeTaxExpenseBenefit`	$48.10M	USD	Annual
Income taxes	`IncomeTaxExpenseBenefit`	$50.44M	USD	Annual
Income taxes	`IncomeTaxExpenseBenefit`	$46.43M	USD	Annual
Net earnings	`NetIncomeLoss`	$112.56M	USD	Annual
Net earnings	`NetIncomeLoss`	$107.73M	USD	Annual
Net earnings	`NetIncomeLoss`	$110.95M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-36.51M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-3.54M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$15.82M	USD	Annual
Unrealized (losses) gains on available-for-sale investments, net of tax of 3,895, ($17,110) and ($2,129), respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-35.76M	USD	Annual
Unrealized (losses) gains on available-for-sale investments, net of tax of 3,895, ($17,110) and ($2,129), respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.68M	USD	Annual
Unrealized (losses) gains on available-for-sale investments, net of tax of 3,895, ($17,110) and ($2,129), respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$11.31M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-7.22M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-19.94M	USD	Annual
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-25.20M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$91.01M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$82.53M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$105.34M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.06	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.90	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.01	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.00	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.89	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.05	USD	Annual
Cash dividends per common share: (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.27	USD	Annual
Cash dividends per common share: (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.23	USD	Annual
Cash dividends per common share: (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.18	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	36.84M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	36.89M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.10M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.23M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.90M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.01M	shares	Annual

Cash Flow Statement 107 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$112.56M	USD	Annual
Net earnings	`NetIncomeLoss`	$107.73M	USD	Annual
Net earnings	`NetIncomeLoss`	$110.95M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.18M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$37.23M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.32M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$4.50M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$6.96M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$7.48M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-2.53M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-2.85M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.30M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$3.52M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$1.86M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$5.96M	USD	Annual
Gain on sale of CyVek	`BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain`	-	USD	Annual
Gain on sale of CyVek	`BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain`	-	USD	Annual
Gain on sale of CyVek	`BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain`	$8.30M	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$262.00K	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$75.00K	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$615.00K	USD	Annual
Net (gain) loss from equity method investees	`IncomeLossFromEquityMethodInvestments`	-	USD	Annual
Net (gain) loss from equity method investees	`IncomeLossFromEquityMethodInvestments`	$570.00K	USD	Annual
Net (gain) loss from equity method investees	`IncomeLossFromEquityMethodInvestments`	-	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-458.00K	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-763.00K	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-592.00K	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$2.33M	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.15M	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$11.75M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$2.90M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$4.71M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$2.22M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$620.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$33.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$554.00K	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.15M	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$243.00K	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.37M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-92.00K	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.68M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$1.03M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-837.00K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$1.88M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-1.94M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$139.36M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$123.56M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$136.76M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$112.71M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$106.75M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$13.47M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$103.61M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$289.41M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.82M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.91M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.45M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$420.10M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$109.18M	USD	Annual
Investment in unconsolidated entity	`PaymentsToAcquireInterestInJointVenture`	-	USD	Annual
Investment in unconsolidated entity	`PaymentsToAcquireInterestInJointVenture`	$10.00M	USD	Annual
Investment in unconsolidated entity	`PaymentsToAcquireInterestInJointVenture`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-352.00K	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-25.00K	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-48.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-31.20M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-426.49M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$49.69M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$45.39M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$47.11M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$43.46M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$8.33M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$1.10M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$9.73M	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$75.00K	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$615.00K	USD	Annual
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$262.00K	USD	Annual
Purchase of common stock for stock bonus plans	`PurchaseOfCommonStockForStockBonusPlans`	-	USD	Annual
Purchase of common stock for stock bonus plans	`PurchaseOfCommonStockForStockBonusPlans`	$573.00K	USD	Annual
Purchase of common stock for stock bonus plans	`PurchaseOfCommonStockForStockBonusPlans`	-	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.82M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLinesOfCredit`	-	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLinesOfCredit`	$163.00M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLinesOfCredit`	-	USD	Annual
Payment on line-of-credit and other	`RepaymentsOfLinesOfCredit`	$94.96M	USD	Annual
Payment on line-of-credit and other	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Payment on line-of-credit and other	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-36.81M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$31.28M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-44.68M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-8.18M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.14M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-570.00K	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$47.11M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-264.04M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$154.78M	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$54.53M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$318.57M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$163.79M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$116.67M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$54.53M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$318.57M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$163.79M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$116.67M	USD	Point-in-time

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balances at June 30, 2012 (in shares)	`CommonStockSharesOutstanding`	37.00M	shares	Point-in-time
Balances at June 30, 2012 (in shares)	`CommonStockSharesOutstanding`	37.15M	shares	Point-in-time
Balances at June 30, 2012	`StockholdersEquity`	$846.93M	USD	Point-in-time
Balances at June 30, 2012	`StockholdersEquity`	$737.54M	USD	Point-in-time
Balances at June 30, 2012	`StockholdersEquity`	$795.26M	USD	Point-in-time
Balances at June 30, 2012	`StockholdersEquity`	$674.44M	USD	Point-in-time
Net earnings	`NetIncomeLoss`	$112.56M	USD	Annual
Net earnings	`NetIncomeLoss`	$107.73M	USD	Annual
Net earnings	`NetIncomeLoss`	$110.95M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-7.22M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-19.94M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-25.20M	USD	Annual
Exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-22,000.00	shares	Annual
Exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-142,000.00	shares	Annual
Exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-141,000.00	shares	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.76M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.38M	USD	Annual
Common stock issued for restricted stock award	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-57.00K	USD	Annual
Common stock issued for restricted stock award	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Common stock issued for restricted stock award	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$1.82M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$45.39M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$43.46M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$47.11M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.86M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.92M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.52M	USD	Annual
Tax benefit from exercise of stock options	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$75.00K	USD	Annual
Tax benefit from exercise of stock options	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$615.00K	USD	Annual
Tax benefit from exercise of stock options	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$262.00K	USD	Annual
Balances at June 30, 2013 (in shares)	`CommonStockSharesOutstanding`	37.00M	shares	Point-in-time
Balances at June 30, 2013 (in shares)	`CommonStockSharesOutstanding`	37.15M	shares	Point-in-time
Balances at June 30, 2013	`StockholdersEquity`	$846.93M	USD	Point-in-time
Balances at June 30, 2013	`StockholdersEquity`	$737.54M	USD	Point-in-time
Balances at June 30, 2013	`StockholdersEquity`	$795.26M	USD	Point-in-time
Balances at June 30, 2013	`StockholdersEquity`	$674.44M	USD	Point-in-time
Surrender and retirement of stock to exercise options	`SurrenderAndRetirementOfStockToExerciseOptionsValue`	$-31.00K	USD	Annual
Surrender and retirement of stock to exercise options	`SurrenderAndRetirementOfStockToExerciseOptionsValue`	$-56.00K	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$39.00K	USD	Annual

Comprehensive Income 3 line items

Line Item	Tag	Value	Unit	Period
Unrealized losses on available-for-sale investments, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-2.13M	USD	Annual
Unrealized losses on available-for-sale investments, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$3.90M	USD	Annual
Unrealized losses on available-for-sale investments, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-17.11M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.